
Foundation Fighting Blindness Celebrates Dr. Jean Bennett’s Breakthrough Award for Gene Therapy for Inherited Retinal Disease
Published on May 22, 2026
COLUMBIA, Md.—Foundation Fighting Blindness celebrates Jean Bennett, MD, who recently won the prestigious 2026 Breakthrough Prize in Life Sciences, awarded to the Children's Hospital of Philadelphia and Penn Medicine team for developing the first FDA-approved gene therapy for an inherited retinal disease. Dr. Bennett, along with her husband, Albert Maguire, MD, and collaborator Katherine High, MD, received this $3 million award for their groundbreaking work that led to Luxturna (voretigene neparvovec-rzyl), the gene therapy that treats RPE65 mutation-associated retinal diseases, according to an announcement from Foundation Fighting Blindness.
